Transcatheter aortic valve replacement: When should it be used in aortic stenosis?;Kathetergestützter Aortenklappenersatz: Eine neue therapeutische Option der Aortenklappenstenose?

Wiener Medizinische Wochenschrift

Volumn 162, Issue 15-16, 2012, Pages 340-348

  Motloch, Lukas Jaroslaw ^a   Reda, Sara ^a   Rottlaender, Dennis ^a   Heigert, Matthias ^a   Hoppe, Uta C ^a  

^a Paracelsus Medizinische Privatniversität Salzburg Universitätsklinik für Innere Medizin II Salzburger Landeskliniken   (Austria)

Author keywords

Aortic stenosis; TAVI; Transapical; Transfemoral

Indexed keywords

ACUTE KIDNEY FAILURE; AORTA STENOSIS; AORTA VALVE; ATRIOVENTRICULAR BLOCK; BLOOD VESSEL INJURY; FEMORAL ARTERY; HUMAN; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; REVIEW; RISK FACTOR; STROKE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSIENT ISCHEMIC ATTACK; VALVULAR HEART DISEASE;

ANGIOPLASTY; AORTIC VALVE STENOSIS; BIOPROSTHESIS; CARDIAC CATHETERIZATION; CLINICAL TRIALS AS TOPIC; COOPERATIVE BEHAVIOR; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INTERDISCIPLINARY COMMUNICATION; POSTOPERATIVE COMPLICATIONS; PROSTHESIS DESIGN; STENTS; TREATMENT OUTCOME;

EID: 84866141116     PISSN: 00435341     EISSN: 1563258X     Source Type: Journal    
DOI: 10.1007/s10354-012-0136-6     Document Type: Review

References (58)

1. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J, 24: 1231-1243, 2003. (Pubitemid 36834640)
2. Lindroos M, Kupari M, Heikkila J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol, 21: 1220-1225, 1993. (Pubitemid 23106200)
3. Schwarz F, Baumann P, Manthey J, et al. The effect of aortic valve replacement on survival. Circulation, 66: 1105-1110, 1982. (Pubitemid 12036848)
4. Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation, 114: e84-231, 2006.
5. Roques F, Nashef SA, Michel P, et al. Risk factors and outcome in European cardiac surgery: analysis of the Euro-SCORE multinational database of 19030 patients. Eur J Cardiothorac Surg, 15: 816-822; discussion 822-813, 1999.
6. Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J, 26: 2714-2720, 2005. (Pubitemid 41746694)
7. Moulopoulos SD, Anthopoulos L, Stamatelopoulos S, Stefadouros M. Catheter-mounted aortic valves. Ann Thorac Surg, 11:423-430,1971.
8. Matsubara T, Yamazoe M, Tamura Y, et al. Balloon catheter with check valves for experimental relief of acute aortic regurgitation. Am Heart J, 124: 1002-1008, 1992.
9. Davies H, Lessof MH, Roberts CI, Ross DN. Homograft replacement of the aortic valve: follow-up studies in twelve patients. Lancet, 1: 926-929, 1965.
10. Andersen HR, Knudsen LL, Hasenkam JM. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J, 13: 704-708, 1992.
11. Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet, 356: 1403-1405, 2000.
12. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation, 106: 3006-3008, 2002. (Pubitemid 35440280)
13. Webb JG, Chandavimol M, Thompson CR, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation, 113: 842-850, 2006.
14. Lichtenstein SV, Cheung A, Ye J, et al. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation, 114: 591-596, 2006. (Pubitemid 44202060)
15. Vahanian A, Alfieri O, Al-Attar N, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J, 29: 1463-1470, 2008. (Pubitemid 351806497)
16. Altiok E, Koos R, Schroder J, et al. Comparison of two-dimensional and three-dimensional imaging techniques for measurement of aortic annulus diameters before transcatheter aortic valve implantation. Heart, 97: 1578-1584, 2011.
17. Messika-Zeitoun D, Serfaty JM, Brochet E, et al. Multimodal assessment of the aortic annulus diameter: implications for transcatheter aortic valve implantation. J Am Coll Cardiol, 55: 186-194, 2010.
18. Ng AC, Delgado V, van der Kley F, et al. Comparison of aortic root dimensions and geometries before and after transcatheter aortic valve implantation by 2- and 3-dimensional transesophageal echocardiography and multislice computed tomography. Circ Cardiovasc Imaging, 3: 94-102, 2010.
19. Kurra V, Schoenhagen P, Roselli EE, et al. Prevalence of significant peripheral artery disease in patients evaluated for percutaneous aortic valve insertion: preprocedural assessment with multidetector computed tomography. J Thorac Cardiovasc Surg, 137: 1258-1264, 2009.
20. Motloch LJ, Rottlaender D, Reda S, et al. Local versus general anesthesia for transfemoral aortic valve implantation. Clin Res Cardiol, 101: 45-53, 2012.
21. Wisser W, Gabriel H, Mächler H, et al. (2010) Positionspapier der ÖKG und ÖGTHC zu katheterunterstützten Herzklappeninterventionen. Österreichische Gesellschaft für Thorax- und Herzchirurgie. http://www.herz-thorax.at/standards/index.php3/Positionspapier der OeKG und OeGTHC 2010. Cited 07 Feb 2012.
22. Webb JG, Altwegg L, Boone RH, et al. Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation, 119: 3009-3016, 2009.
23. Ye J, Cheung A, Lichtenstein SV, et al. Transapical transcatheter aortic valve implantation: follow-up to 3 years. J Thorac Cardiovasc Surg, 139: 1107-1113; 1113 e1101, 2010.
24. Walther T, Schuler G, Borger MA, et al. Transapical aortic valve implantation in 100 consecutive patients: comparison to propensity-matched conventional aortic valve replacement. Eur Heart J, 31: 1398-1403, 2010.
25. Leon MB, Smith CR, Mack M, et al. Transcatheter aorticvalve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med, 363: 1597-1607, 2010.
26. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med, 364: 2187-2198, 2011.
27. Rodes-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol, 55: 1080-1090, 2010.
28. Khawaja MZ, Haworth P, Ghuran A, et al. Transcatheter aortic valve implantation for stenosed and regurgitant aortic valve bioprostheses CoreValve for failed bioprosthetic aortic valve replacements. J Am Coll Cardiol, 55: 97-101, 2010.
29. Webb JG, Wood DA, Ye J, et al. Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation, 121: 1848-1857, 2010.
30. Ducrocq G, Francis F, Serfaty JM, et al. Vascular complications of transfemoral aortic valve implantation with the Edwards SAPIEN prosthesis: incidence and impact on outcome. EuroIntervention, 5: 666-672, 2010.
31. Bleiziffer S, Ruge H, Mazzitelli D, et al. Results of percutaneous and transapical transcatheter aortic valve implantation performed by a surgical team. Eur J Cardiothorac Surg, 35: 615-620; discussion 620-611, 2009.
32. Al-Attar N, Raffoul R, Himbert D, Brochet E, Vahanian A, Nataf P. False aneurysm after transapical aortic valve implantation. J Thorac Cardiovasc Surg, 137: e21-22, 2009.
33. Motloch LJ, Reda S, Rottlaender D, et al. Postprocedural atrial fibrillation after transcatheter aortic valve implantation versus surgical aortic valve replacement. Ann Thorac Surg, 93: 124-131, 2012.
34. Piazza N, Grube E, Gerckens U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention, 4: 242-249, 2008.
35. Erkapic D, Kim WK, Weber M, et al. Electrocardiographic and further predictors for permanent pacemaker requirement after transcatheter aortic valve implantation. Europace, 12: 1188-1190, 2010.
36. Bleiziffer S, Ruge H, Horer J, et al. Predictors for new-onset complete heart block after transcatheter aortic valve implantation. JACC Cardiovasc Interv, 3: 524-530, 2010.
37. Al Ali AM, Altwegg L, Horlick EM, et al. Prevention and management of transcatheter balloon-expandable aortic valve malposition. Catheter Cardiovasc Interv, 72: 573-578, 2008.
38. Aregger F, Wenaweser P, Hellige GJ, et al. Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement. Nephrol Dial Transplant, 24: 2175-2179, 2009.
39. Ghanem A, Muller A, Nahle CP, et al. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. J Am Coll Cardiol, 55: 1427-1432, 2010.
40. Kahlert P, Knipp SC, Schlamann M, et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation, 121: 870-878, 2010.
41. Detaint D, Lepage L, Himbert D, et al. Determinants of significant paravalvular regurgitation after transcatheter aortic valve: implantation impact of device and annulus discongruence. JACC Cardiovasc Interv, 2: 821-827, 2009.
42. Cribier A, Eltchaninoff H, Tron C, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol, 47: 1214-1223, 2006.
43. Abdel-Wahab M, Zahn R, Horack M, et al. Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry. Heart, 97: 899-906, 2011.
44. Thomas M, Schymik G, Walther T, et al. One-Year Outcomes of Cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry: the European registry of transcatheter aortic valve implantation using the edwards SAPIEN valve. Circulation, 124: 425-433, 2011.
45. Ludman PF. The United Kingdom transcatheter aortiv valve registry - outcomes to December 2009 and update. Heart, 97: 2011.
46. Zahn R, Gerckens U, Grube E, et al. Transcatheter aortic valve implantation: first results from a multi-centre realworld registry. Eur Heart J, 32: 198-204, 2011.
47. Petronio AS, De Carlo M, Bedogni F, et al. Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the CoreValve revalving system. Circ Cardiovasc Interv, 3: 359-366, 2010.
48. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol, 50: 69-76, 2007. (Pubitemid 46970878)
49. Himbert D, Descoutures F, Al-Attar N, et al. Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. J Am Coll Cardiol, 54: 303-311, 2009.
50. Walther T, Simon P, Dewey T, et al. Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation, 116: I240-245, 2007. (Pubitemid 47480797)
51. Al-Attar N, Himbert D, Descoutures F, et al. Transcatheter aortic valve implantation: selection strategy is crucial for outcome. Ann Thorac Surg, 87: 1757-1762; discussion 1762-1753, 2009.
52. Osten MD, Feindel C, Greutmann M, et al. Transcatheter aortic valve implantation for high risk patients with severe aortic stenosis using the Edwards Sapien balloon-expandable bioprosthesis: a single centre study with immediate and medium-term outcomes. Catheter Cardiovasc Interv, 75: 475-485, 2010.
53. Svensson LG, Dewey T, Kapadia S, et al. United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann Thorac Surg, 86: 46-54; discussion 54-45, 2008.
54. Thielmann M, Wendt D, Eggebrecht H, et al. Transcatheter aortic valve implantation in patients with very high risk for conventional aortic valve replacement. Ann Thorac Surg, 88: 1468-1474, 2009.
55. Ferrari E, Sulzer C, Marcucci C, Rizzo E, Tozzi P, von Segesser LK. Transapical aortic valve implantation without angiography: proof of concept. Ann Thorac Surg, 89: 1925-1932, 2010.
56. Nielsen HH, Andersen HR, Hjortdal VE, et al. Catheter-based aortic valve substitution. Initial experiences with stent valve implantation. Ugeskr Laeger, 171: 2277-2281, 2009.
57. Fusari M, Alamanni F, Bona V, et al. Transcatheter aortic valve implantation in the operating room: early experience. J Cardiovasc Med (Hagerstown), 10: 383-393, 2009.
58. Spargias K, Manginas A, Pavlides G, et al. Transcatheter aortic valve implantation: first Greek experience. Hellenic J Cardiol, 49: 397-407, 2008.